Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection : a case series from Amiens University Hospital
Objective: Since the outbreak of the COVID-19 pandemic, several cases of pituitary apoplexy (PA) following a SARS-CoV-2 infection have been described in several countries. Here, we describe a case series of PA occurring in the aftermath of a SARS-CoV-2 infection to alert physicians about possible neuro-endocrinological damage caused by the virus that can lead to visual sequelae and hypopituitarism.
Design and methods: We retrospectively identified all the adult patients treated at Amiens University Hospital between March 2020 and May 2021 for PA confirmed by cerebral imaging and following an RT-PCR-confirmed SARS-CoV-2 infection.
Results: Eight cases (six women, two men) occurred between March 2020 and May 2021 and were reviewed in this study. The mean age at diagnosis was 67.5 ± 9.8 years. Only one patient had a 'known' non-functional pituitary macroadenoma. The most common symptom of PA was a sudden headache. Brain imaging was typical in all cases. Only two patients required decompression surgery, whereas the others were managed conservatively. The clinical outcome was favorable for all patients but without recovery of their pituitary deficiencies. There was no diabetes insipidus.
Conclusion: This case series, the largest in the literature, reinforces the strength, consistency, and coherence of the association between SARS-CoV-2 infection and PA. Our study provides support for the hypothesis that SARS-CoV-2 may be a new precipitating factor for PA. It is essential that practitioners be alerted about possible pituitary disease due to the virus so that such patients are recognized and appropriately managed, hence improving their prognosis.
| Errataetall: |
CommentIn: Eur J Endocrinol. 2022 Sep 29;187(5):L1-L2. - PMID 36070418 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:187 |
|---|---|
| Enthalten in: |
European journal of endocrinology - 187(2022), 3 vom: 01. Sept., Seite K19-K25 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Balmain, Joe [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 29.07.2022 Date Revised 19.10.2022 published: Electronic-Print CommentIn: Eur J Endocrinol. 2022 Sep 29;187(5):L1-L2. - PMID 36070418 Citation Status MEDLINE |
|---|
| doi: |
10.1530/EJE-22-0056 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344154793 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344154793 | ||
| 003 | DE-627 | ||
| 005 | 20231226022118.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1530/EJE-22-0056 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1147.xml |
| 035 | |a (DE-627)NLM344154793 | ||
| 035 | |a (NLM)35895701 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Balmain, Joe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection |b a case series from Amiens University Hospital |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.07.2022 | ||
| 500 | |a Date Revised 19.10.2022 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a CommentIn: Eur J Endocrinol. 2022 Sep 29;187(5):L1-L2. - PMID 36070418 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Objective: Since the outbreak of the COVID-19 pandemic, several cases of pituitary apoplexy (PA) following a SARS-CoV-2 infection have been described in several countries. Here, we describe a case series of PA occurring in the aftermath of a SARS-CoV-2 infection to alert physicians about possible neuro-endocrinological damage caused by the virus that can lead to visual sequelae and hypopituitarism | ||
| 520 | |a Design and methods: We retrospectively identified all the adult patients treated at Amiens University Hospital between March 2020 and May 2021 for PA confirmed by cerebral imaging and following an RT-PCR-confirmed SARS-CoV-2 infection | ||
| 520 | |a Results: Eight cases (six women, two men) occurred between March 2020 and May 2021 and were reviewed in this study. The mean age at diagnosis was 67.5 ± 9.8 years. Only one patient had a 'known' non-functional pituitary macroadenoma. The most common symptom of PA was a sudden headache. Brain imaging was typical in all cases. Only two patients required decompression surgery, whereas the others were managed conservatively. The clinical outcome was favorable for all patients but without recovery of their pituitary deficiencies. There was no diabetes insipidus | ||
| 520 | |a Conclusion: This case series, the largest in the literature, reinforces the strength, consistency, and coherence of the association between SARS-CoV-2 infection and PA. Our study provides support for the hypothesis that SARS-CoV-2 may be a new precipitating factor for PA. It is essential that practitioners be alerted about possible pituitary disease due to the virus so that such patients are recognized and appropriately managed, hence improving their prognosis | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Jarebi, Meshal |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Salameh, Abdallah |e verfasserin |4 aut | |
| 700 | 1 | |a Toussaint, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Timmerman, Marine |e verfasserin |4 aut | |
| 700 | 1 | |a Chenin, Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Constans, Jean-Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Desailloud, Rachel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of endocrinology |d 1996 |g 187(2022), 3 vom: 01. Sept., Seite K19-K25 |w (DE-627)NLM074863665 |x 1479-683X |7 nnns |
| 773 | 1 | 8 | |g volume:187 |g year:2022 |g number:3 |g day:01 |g month:09 |g pages:K19-K25 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1530/EJE-22-0056 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 187 |j 2022 |e 3 |b 01 |c 09 |h K19-K25 | ||